SecBot SecBot
8-K ·Filed Jun 26, 2026

PAHC

PHIBRO ANIMAL HEALTH CORP
NEUTRAL
Impact 2/10
Horizondays Processed4mo ago SEC0001104659-26-078323
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

This is a routine CEO appointment with no material financial implications. Monitor for any strategic shifts under the new CEO, but no immediate trading catalyst is present.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$31.81
T+0 close · Jun 26, 2026 · via day close
Latest settled
+10.50%
T+60 · $35.15
Vs SPY
+6.11%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 29 $31.81entry
  2. T+1 · 5mo ago −1.29%α −2.07% · $31.40
  3. T+5 · 4mo ago +7.29%α +5.91% · $34.13
  4. T+20 · 4mo ago +6.99%α +7.27% · $34.04
  5. T+60 · 8w ago +10.50%α +6.11% · $35.15
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Phibro Animal Health appointed Daniel (Dani) Bendheim as CEO and President effective July 1, 2026, with an employment agreement including a base salary of $850,000, target bonus of 50% of base, and a grant of 300,000 performance-based RSUs vesting based on stock price targets ($70–$100+ by June 30, 2031). This is a routine leadership transition with standard compensation terms and no financial data or red flags.

Key Facts

  • Daniel Bendheim appointed CEO and President effective July 1, 2026
  • Base salary of $850,000 per year with target bonus of 50% of base salary
  • Initial grant of 300,000 performance-based RSUs vesting based on 90-day average stock price from $70 to $100+ by June 30, 2031
  • Annual time-vesting RSU target value of approximately 50% of base salary
  • Change-in-control provisions allow accelerated vesting under certain conditions

Financial Impact

No immediate financial impact; the 300,000 RSU grant is performance-based and long-dated, representing potential dilution of approximately 0.7% of current shares outstanding (based on market cap of $1.3B and stock price context).

dilution

Risk Factors

  • None from this filing; the appointment appears planned and uncontroversial

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
10% bullish (10 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001104659-26-078323
Document: 0001104659-26-078323-index-headers.html0001104659-26-078323
Document: 0001104659-26-078323-index.html0001104659-26-078323
Document: 0001104659-26-078323.txt0001104659-26-078323

Track record

9 reports on PAHC

Performance horizon

1 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +37.96% at T+20 after the Apr 27, 2026 report. 2 of 3 went positive at some point.

Filters
  1. Nov 4, 202612d ago 8-K Neutral 4/10 Entry $35.40 to $35.46 Now $35.02 −1.07% ▲ +0.17% −3.12% vs SPY
  2. Nov 3, 202613d ago 8-K Neutral 2/10 Entry $39.43 to $35.15 Now $35.02 −11.18% ▼ −10.85% −9.94% vs SPY
  3. Oct 19, 202628d ago SC 13G/A Bearish 5/10 Entry $38.80 to $38.38 Now $35.02 +9.74% ▲ +1.08% +1.16% vs SPY
  4. Jul 28, 202615w ago 8-K Neutral 2/10 Entry $36.95 to $36.01 Now $35.02 −5.22% ▼ −2.54% −8.07% vs SPY
  5. Jun 26, 202620w ago 8-K Neutral 2/10 Viewing Entry $31.81 to $34.13 Now $35.02 +10.09% ▲ +7.29% +5.91% vs SPY
  6. May 6, 202627w ago 8-K Bullish 6/10 Entry $43.16 to $35.26 Now $35.02 −18.86% ▼ −18.30% −19.81% vs SPY
  7. May 5, 202627w ago 8-K Neutral 2/10 Entry $58.50 to $36.58 Now $35.02 −40.14% ▼ −37.47% −38.60% vs SPY
  8. Apr 30, 202628w ago 8-K Neutral 4/10 Entry $54.66 to $39.83 Now $35.02 −35.93% ▼ −27.13% −29.47% vs SPY
  9. Apr 27, 202629w ago 8-K Bearish 5/10 Entry $54.29 to $54.68 Now $35.02 +35.49% ▼ −0.72% +0.97% vs SPY
Showing 9 of 9

US Market Status

Market Closed · Opens in 5h 41m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 26, 2026